Myeloma Center


February 23, 2024

UAMS Myeloma Patient Grateful for ‘Life Changing’ Treatment

Nathan Tidwell

Jim and Laurie Schepers.

Jim Schepers remembers getting a call he didn’t want in April 2020. The call was from Frits van Rhee, M.D., Ph.D., clinical director of the Myeloma Center at the University of Arkansas for Medical Sciences (UAMS) and Schepers’ physician — cancer had returned. “When we found out the cancer was back, Dr. van Rhee called…


December 15, 2023

Nurse Passionate About Success, Impact of UAMS Myeloma Center

Kev' Moye

Heather Brown, APRN

Heather Brown, APRN, a nurse practitioner for the University of Arkansas for Medical Sciences (UAMS) Winthrop P. Rockefeller Cancer Institute’s Myeloma Center, appreciates the opportunity to serve the patients. A 2001 graduate of the UAMS College of Nursing, Brown quickly learned about myeloma as the center opened shortly after she was hired by the institute….


Intake Team Serves as Source of Comfort for Myeloma Center Patients

Chris Carmody

(Left to right) Christy Bunting, Amy Ford, Melissa Thomas, April Thomas.

For new patients of the UAMS Myeloma Center, the intake process provides their first impression of the support they’ll receive during a difficult period of their lives. “It’s important that we help them get established and make sure they’re comfortable coming here,” said Christy Bunting, an intake coordinator in the Myeloma Center. “We want them…


UAMS Myeloma Researcher Sees‘ Impressive’ Results in Clinical Trials of Bispecific Antibody Treatments

David Robinson

Carolina Schinke, M.D.

Many patients at the UAMS Myeloma Center have relapsed refractory myeloma, meaning they have nearly run out of effective treatment options. Fortunately, the center has talented clinical researchers like Carolina Schinke, M.D., with access to the latest medications, including promising study drugs. Schinke is leading a clinical trial at UAMS of a promising new bispecific…


December 14, 2023

New Immune Therapies Provide Promising Advances in Myeloma Care

News Staff

Frits van Rhee, MD, Ph.D.

By Frits van Rhee, MD, Ph.D. Since the late 1990s, 16 drugs have been approved for the treatment of multiple myeloma, including proteasome inhibitors, such as bortezomib and carfilzomib, and the immunomodulatory class of agents comprising thalidomide, lenalidomide and pomalidomide. Immune therapy with the antibody daratumumab was first approved in 2015. These three classes of…


Expanding the Field: Clinical Trials Diversity Benefits Myeloma Research

Nathan Tidwell

Samer Al Hadidi, M.D.

Clinical trials have long been an established part of medical research. The University of Arkansas for Medical Sciences (UAMS) Myeloma Center and the Clinical Trials Office work together to create a more diverse pool of clinical trial participants in the continuing research of multiple myeloma. Samer Al Hadidi, M.D., is a driving force in this…


November 20, 2023

UAMS Myeloma Center Hits Impressive Milestone, Sees 1000th Article Published

Nathan Tidwell

Frits van Rhee, M.D, Ph.D.

Researchers and physicians with the Myeloma Center at the University of Arkansas for Medical Sciences (UAMS) recently published their 1,000th article, an impressive milestone that demonstrates the center’s high level of scholarship. “This is a remarkable achievement by our amazing Myeloma Center physicians and researchers,” said Frits van Rhee, M.D., Ph.D., clinical director of the…


August 8, 2023

Harold Dean Named Leukemia & Lymphoma Society’s Hematology-Oncology Social Worker of the Year

Nathan Tidwell

Harold Dean

LITTLE ROCK — Harold Dean, MSW, social work program manager for the Myeloma Center at the University of Arkansas for Medical Sciences (UAMS), has been named the Leukemia & Lymphoma Society Hematology-Oncology Social Worker of the Year. Dean received the award during the Association of Oncology Social Work annual conference June 19-21 in New Orleans….


August 1, 2023

National Cancer Institute Awards UAMS Researchers $2.26 Million to Continue Multiple Myeloma Study

Nathan Tidwell

Bellido, Delgado-Calle

LITTLE ROCK — University of Arkansas for Medical Sciences (UAMS) researchers Teresita Bellido, Ph.D., and Jesus Delgado-Calle, Ph.D., recently received a five-year, $2.26 million continuation award from the National Cancer Institute. Bellido is a professor and chair of the Department of Physiology and Cell Biology in the UAMS College of Medicine, while Delgado-Calle is an…


July 7, 2023

Little Rock Subaru Delivers Blankets, Activity Boxes to UAMS Myeloma Center

Nathan Tidwell

Subaru Donation

The Subaru Loves to Care initiative returned to the University of Arkansas for Medical Sciences (UAMS) this summer. In partnership with the Leukemia & Lymphoma Society, Subaru of Little Rock delivered 100 blankets and 30 arts and crafts kits to the Myeloma Center on June 21. The blankets are intended to provide comfort for myeloma…



Next page